Akebia Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.

CEO

John P. Butler

CEOJohn P. Butler

Employees

181

Employees181

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2007

Founded2007

Employees

181

Employees181

AKBA Key Statistics

Market cap

787.48M

Market cap787.48M

Price-Earnings ratio

-16.16

Price-Earnings ratio-16.16

Dividend yield

—

Dividend yield—

Average volume

3.47M

Average volume3.47M

High today

$2.97

High today$2.97

Low today

$2.80

Low today$2.80

Open price

$2.80

Open price$2.80

Volume

3.25M

Volume3.25M

52 Week high

$4.08

52 Week high$4.08

52 Week low

$1.24

52 Week low$1.24

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.